Ajooni Biotech Ltd (AJOONI) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Ajooni Biotech Ltd on NSE and BSE, with an AI summary of each filing.
AJOONI BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 13 Nov 2026, 5:30 am
Ajooni Biotech Board Meeting on 13th Nov'26 to Consider Half-Yearly Results Ajooni Biotech Limited has scheduled a meeting of its Board of Directors on 13th Nov'26 to inter-alia consider and approve the company's unaudited financial results for the half-year ended Sep'26.
To consider and approve the unaudited financial results for the period ended September 30, 2026
Intimation · 13 Nov 2026, 5:30 am
Ajooni Biotech Board Meeting Scheduled for 13th Nov'26 to Consider Q2 Results Ajooni Biotech Limited has scheduled a meeting of its Board of Directors on 13th Nov'26 at 10:30 AM at its Corporate Office in Mohali, Punjab. The primary agenda of the meeting is to review, consider, and approve the company's unaudited financial results for the quarter and half-year ended 30th Sep'26, alongside other general business matters.
Ajooni Biotech Limited has informed the Exchange regarding 'Undertaking of functional website'.
Others (Uncategorized) · 19 Oct 2026, 6:06 pm
Ajooni Biotech Confirms Functional Website Compliance Under SEBI LODR Regulations Ajooni Biotech Limited submitted an official undertaking to the National Stock Exchange of India on 19th Oct'26, confirming that its corporate website (www.ajoonibiotech.com) is fully updated and functional. The submission ensures regulatory compliance in accordance with Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Ajooni Biotech Limited has informed the Exchange regarding 'Confirmation Certificate as per Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the Quarter Ended on 30th June, 2026'.
Others (Uncategorized) · 15 Oct 2026, 5:41 pm
Ajooni Biotech Submits SEBI Regulation 74(5) Dematerialisation Certificate for Q2 FY27 Ajooni Biotech Limited submitted its compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th Sep'26. Issued by Registrar and Share Transfer Agent Cameo Corporate Services Limited on 6th Oct'26, the certificate confirms that securities received for dematerialisation during the period were duly processed, listed on relevant stock exchanges, and physical certificates were mutilated and cancelled within the prescribed timelines.
Ajooni Biotech Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
Outcome · 14 Aug 2026, 10:52 pm
Ajooni Biotech Q1FY27: Revenue Doubles but Profit Declines Ajooni Biotech reported a mixed performance for Q1 ended 30-Jun'26. Revenue from operations doubled to ₹6,349.07 lakh, a 103.1% YoY increase from ₹3,126.77 lakh. However, Net Profit declined by 44.7% YoY to ₹43.18 lakh from ₹78.14 lakh in the prior year's quarter. Sequentially, revenue grew 4.7% while profit fell sharply by 54.4%. The profit decline was driven by significantly higher material costs, which rose 112.7% YoY, and a 469% YoY surge in finance costs, compressing margins despite the strong top-line growth.
Ajooni Biotech Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
Outcome · 14 Aug 2026, 9:20 pm
Ajooni Biotech Limited has informed the Exchange regarding allotment of 9000000 securities pursuant to Preferential Issue at its meeting held on August 12, 2026
Others (Uncategorized) · 12 Aug 2026, 3:59 pm
Ajooni Biotech Board Approves Preferential Allotment of 90 Lakh Shares Ajooni Biotech's Board, on Aug 12, '26, approved a preferential allotment of 90,00,000 equity shares to Healthy Biosciences Limited. The shares, with a face value of ₹2 each, were issued at a price of ₹4.30 per share, including a premium of ₹2.30. This transaction will raise a total of ₹3.87 crore for the company. The shares are fully paid-up upon receipt of the full subscription amount.
AJOONI BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 14-Aug-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2026 .
Intimation · 14 Aug 2026, 5:30 am
Ajooni Biotech Board Meeting for Q1 FY27 Results on 14-Aug'26 Ajooni Biotech has scheduled a Board Meeting for 14-Aug'26. The primary agenda is to consider and approve the company's unaudited financial results for the first quarter ending Jun'26. This meeting will set the stage for the company's Q1 performance announcement, a key event for investors monitoring its financial health and operational execution.
To consider and approve the financial results for the period ended Jun 30, 2026
Intimation · 30 Jun 2026, 5:30 am
Ajooni Biotech Board to Approve Q1FY27 Results on 14th Aug'26 Ajooni Biotech Limited has scheduled a Board of Directors meeting for 14th Aug'26. The primary agenda is to consider and approve the un-audited financial results for the quarter ended 30th Jun'26. This meeting will determine the company's performance for the first quarter of the fiscal year 2026-2027. Any other matters may also be discussed with the permission of the Chair.
Ajooni Biotech Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.
Others (Uncategorized) · 31 Jul 2026, 11:06 pm
Ajooni Biotech Increases Authorised Share Capital Ajooni Biotech announced that shareholders approved an increase in its Authorised Share Capital via special resolution at its 16th AGM on 29th Jul'26. The new capital is set at Rs. 70 crore, divided into 35 crore equity shares with a face value of Rs. 2 each. The voting results for the amendment to the Memorandum of Association were declared on 31st Jul'26. This move provides the company with greater flexibility for potential future capital raising or corporate actions.
Ajooni Biotech Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on July 29, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 31 Jul 2026, 10:58 pm
Ajooni Biotech Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 29, 2026
Annual General Meeting · 29 Jul 2026, 8:11 pm
Ajooni Biotech Limited has informed the Exchange regarding 'Undertaking of functional website'.
Others (Uncategorized) · 14 Jul 2026, 4:07 pm
Ajooni Biotech Confirms Website Functionality Under SEBI Regulations Ajooni Biotech Limited has informed the National Stock Exchange that its website, www.ajoonibiotech.com, is updated and fully functional. This declaration, dated 14 Jul'26, confirms the company's compliance with Regulation 46 of the SEBI (LODR) Regulations, 2015. The undertaking serves as a routine regulatory filing, ensuring that mandatory corporate disclosures and investor information are accessible as required by listing obligations. No other material information was disclosed in the filing.
Ajooni Biotech Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on July 29, 2026
Annual General Meeting · 01 Jul 2026, 4:08 pm
Ajooni Biotech Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.
Others (Uncategorized) · 29 Jun 2026, 9:08 pm
Ajooni Biotech Board Approves Increase in Authorised Share Capital Ajooni Biotech's Board of Directors approved a proposal on 29 Jun'26 to increase the company's Authorised Share Capital. The new proposed capital is Rs. 70 crore, comprising 35 crore equity shares with a face value of Rs. 2 each. This corporate action is subject to shareholder approval at the upcoming Annual General Meeting scheduled for 29 Jul'26. The amendment will alter Clause V of the company's Memorandum of Association.
Ajooni Biotech Limited has informed the Exchange regarding Outcome of Board Meeting held on Jun 29, 2026.
Outcome · 29 Jun 2026, 8:57 pm
Ajooni Biotech Approves Capital Increase and Preferential Allotment to Promoters On 29 Jun'26, Ajooni Biotech's Board approved increasing its authorized share capital from Rs. 50 crore to Rs. 70 crore. The board also approved a preferential issue of 90 lakh equity shares at Rs. 4.30 per share, aggregating to Rs. 3.87 crore, to Healthy Biosciences Limited, part of the promoter group. Post-allotment, the promoter and promoter group's shareholding will increase from 26.89% to 30.53%. These resolutions require shareholder approval at the upcoming AGM on 29 Jul'26.